Clinical Trial B: Azathioprine immunosuppression and disease modification in Parkinson’s disease (AIM-PD)
Clinical Trial C: UPR signalling/Trazodone
Links
instagram加速器安卓下载
instagram免费永久加速器
Career
Welcome to the Cambridge Centre for Parkinson-Plus
2024免费加速器- quickq下载
Read about the team of Principal Investigators at the Cambridge Centre for Parkinson-Plus.
Read more
2024免费加速器- quickq下载
Read about our Science Discovery programmes that aim at understanding of disease mechanisms and development of new biomarkers for Parkinson-Plus diseases.
Read more
2024免费加速器- quickq下载
Read about our Clinical Translational Research and Clinical Trials in the Centre. We want to discover novel therapeutics for patients with Parkinson-Plus syndromes.
Read more
2024免费加速器- quickq下载
instagram免费永久加速器
2024免费加速器- quickq下载
Would you like to take part in our research programmes? Please contact us.
Read more
Open positions
Read more
Links
Read more
Latest news
Cambridge Centre for Parkinson-Plus launched
Mar 01, 2018
Two drugs that prevent neurodegeneration in mice.
Apr 20, 2017
View all news
2024免费加速器- quickq下载
We may use cookies to record some preference settings and to analyse how
you use our web site. We may also use external analysis systems which may
set additional cookies to perform their analysis.These cookies (and any
others in use) are detailed in our site privacy and cookie policies and are
integral to our web site. You can delete or disable these cookies in your
web browser if you wish but then our site may not work correctly.